SPC
EIGR

Slate Path Capital’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Slate Path Capital’s Portfolio EIGR Stock Details EIGR Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-255,000
Closed -$1.92M – 52
2022
Q3 		$1.92M Hold
255,000
– – 0.12% 39
2022
Q2 		$1.61M Hold
255,000
– – 0.1% 37
2022
Q1 		$2.12M Buy
+255,000
New +$2.12M 0.11% 35